Evidence-based cardiovascular therapies and achievement of therapeutic goals in diabetic patients with coronary heart disease attended in primary care

JM Mostaza-Prieto, L Martín-Jadraque, I López… - American Heart …, 2006 - Elsevier
BACKGROUND: Diabetic patients have a higher rate of recurrent cardiovascular events and
death than nondiabetic individuals. Although partially attributable to lower use of evidence …

Secondary prevention of coronary artery disease in high-risk diabetic patients

C Giorda, M Maggini, SS Alegiani, S Turco… - Nutrition, Metabolism …, 2003 - Elsevier
Abstract BACKGROUND AND AIM:: To compare guideline implementation and the actual
delivery of secondary prevention for coronary artery disease in the cohort of Italian diabetic …

Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a …

M Anselmino, M Bartnik, K Malmberg… - European Journal of …, 2007 - academic.oup.com
Objective To investigate the diagnostic and therapeutic strategies applied to patients
currently treated for coronary artery disease (CAD) in relation to the presence of diabetes …

Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro …

M Anselmino, K Malmberg, J Öhrvik… - European Journal of …, 2008 - academic.oup.com
Background Patients with diabetes mellitus (DM) and coronary artery disease (CAD) have a
poor prognosis. Underutilization and reduced efficacy of evidence-based medications (EBM) …

Limited application of prevention measures in patients with diabetes mellitus type 2 and coronary artery disease in Spain. DIETRIC study

LR Padial, CM Bellido, JA López… - Revista clinica …, 2005 - pubmed.ncbi.nlm.nih.gov
Introduction and objectives Diabetes is a disease with high prevalence that involves high
mortality. The control of risk factors reduces the cardiovascular complications. The objective …

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational …

V Gyberg, D De Bacquer, G De Backer… - Cardiovascular …, 2015 - Springer
Background In order to influence every day clinical practice professional organisations issue
management guidelines. Cross-sectional surveys are used to evaluate the implementation …

[PDF][PDF] Secondary prevention therapies for coronary heart disease in patients with type 2 diabetes: an audit

KK Sharma, S Guptha, R Gupta - JAPI, 2012 - researchgate.net
Background: Use of evidence based pharmacotherapy reduces risk of secondary events in
patients with established coronary heart disease (CHD). To determine frequency of their use …

Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines?

PB George, KJ Tobin, RA Corpus, WH Devlin… - American heart …, 2001 - Elsevier
Background Diabetic patients are at increased risk for both macrovascular and
microvascular disease compared with nondiabetic patients. Methods We conducted a …

Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the …

V Gyberg, K Kotseva, J Dallongeville… - European journal of …, 2015 - academic.oup.com
Purpose The aim was to investigate the use of cardioprotective drug therapies (aspirin or
other antiplatelet agents, β-blockade, renin-angiotensin-aldosterone-system-blockade …

Under-prescribing of cardiovascular therapies for diabetes in primary care

KE Bennett, D Williams, J Feely - European journal of clinical …, 2003 - Springer
Objective To determine the extent to which cardiovascular therapies are prescribed in
primary care for those with diabetes, compared with those without diabetes. Methods …